Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study

BACKGROUND: New prognostic markers may be of value in determining survival and informing decisions of adjuvant treatment in the heterogeneous group of soft tissue sarcomas known as malignant fibrous sarcomas (MFS). Increased CD44 expression has been associated with a better outcome in cancers such a...

Full description

Saved in:
Bibliographic Details
Main Authors: Matuschek, Christiane, Lehnhardt, Marcus, Gerber, Peter Arne, Poremba, Christopher, Hamilton, Jackson, Lammering, Guido, Orth, Klaus, Budach, Wilfried, Bojar, Hans, Bölke, Edwin, Peiper, Matthias
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942188/
https://ncbi.nlm.nih.gov/pubmed/24491153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-19-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items